Table 1.
Baseline data and test results of each functional segment of SurgSmart models
| Model name | Dataset | Labeling | Labeling frames | Total frames | Videos | Annotating κ | Precision (%) | Recall | mAP | Accuracy | F1-score |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Surgical phase and steps | Training | IT | 27 131 | 215 170 | 178 | 0.90 | |||||
| EA | 10 877 | ||||||||||
| AL | 13 511 | ||||||||||
| MHT | 78 128 | ||||||||||
| DGB | 34 868 | ||||||||||
| EG | 20 312 | ||||||||||
| COR | 30 343 | ||||||||||
| Validating | IT | 2281 | 20 906 | 22 | |||||||
| EA | 825 | ||||||||||
| AL | 776 | ||||||||||
| MHT | 9066 | ||||||||||
| DGB | 3531 | ||||||||||
| EG | 1855 | ||||||||||
| COR | 2572 | ||||||||||
| Testing | IT | 4110 | 25 598 | 22 | 91.31 | 84.38 | NA | 88.61 | 78.61 | ||
| EA | 1841 | 78.53 | 82.08 | ||||||||
| AL | 1047 | 98.97 | 56.62 | ||||||||
| MHT | 9865 | 90.36 | 97.89 | ||||||||
| DGB | 3598 | 85.98 | 91.28 | ||||||||
| EG | 2705 | 92.00 | 83.25 | ||||||||
| COR | 2432 | 80.48 | 91.84 | ||||||||
| Parkland grading | Training | Mild (grade 1–2) | 3862 | 6525 | 172 | 0.97 | |||||
| Severe (grade 3–5) | 2663 | ||||||||||
| Validating | Mild (grade 1–2) | 468 | 850 | 22 | |||||||
| Severe (grade 3–5) | 382 | ||||||||||
| Testing | Mild (grade 1–2) | 468 | 858 | 22 | 100.00 | 92.31 | NA | 95.45 | 95.37 | ||
| Severe (grade 3–5) | 390 | 90.00 | 100.00 | ||||||||
| Critical division action | Training | Artery/cystic duct division | 4550 | 5120 | 142 | 0.92 | |||||
| Validating | 196 | 22 | |||||||||
| Testing | 374 | 23 | 75.08 | 89.31 | NA | 98.49 | 76.94 | ||||
| CVSI | Training | −1 | 5906 | 21 863 | 339 | 0.89 | |||||
| 0 | 3894 | ||||||||||
| 1 | 11 293 | ||||||||||
| 2 | 770 | ||||||||||
| Validating | −1 | 658 | 2126 | 76 | |||||||
| 0 | 466 | ||||||||||
| 1 | 924 | ||||||||||
| 2 | 78 | ||||||||||
| Testing | −1 | 19 | 5305 | 22 | 61.29 | 100.00 | 76.86 | 80.64 | 70.66 | ||
| 0 | 675 | 39.02 | 82.67 | ||||||||
| 1 | 4579 | 96.84 | 80.24 | ||||||||
| 2 | 32 | 54.00 | 84.38 | ||||||||
| CVSII | Training | −1 | 6144 | 22 298 | 342 | 0.88 | |||||
| 0 | 15 560 | ||||||||||
| 2 | 594 | ||||||||||
| Validating | −1 | 738 | 2273 | 78 | |||||||
| 0 | 1429 | ||||||||||
| 2 | 106 | ||||||||||
| Testing | −1 | 29 | 6060 | 22 | 24.14 | 96.55 | 71.04 | 97.62 | 59.42 | ||
| 0 | 5994 | 99.68 | 97.91 | ||||||||
| 2 | 37 | 33.93 | 51.35 | ||||||||
| CVSIII | Training | −1 | 5950 | 20 337 | 316 | 0.89 | |||||
| 0 | 8690 | ||||||||||
| 1 | 3985 | ||||||||||
| 2 | 1712 | ||||||||||
| Validating | −1 | 671 | 2006 | 74 | |||||||
| 0 | 830 | ||||||||||
| 1 | 323 | ||||||||||
| 2 | 182 | ||||||||||
| Testing | −1 | 19 | 4530 | 22 | 37.25 | 100.00 | 66.49 | 78.87 | 56.82 | ||
| 0 | 3541 | 92.48 | 84.69 | ||||||||
| 1 | 896 | 51.17 | 56.36 | ||||||||
| 2 | 74 | 20.08 | 67.57 |
The labeling of CVS=−1 means no area for CVS evaluation was detected.
AL, adhesion lysis; COR, clear the operative region; CVSI, hepatocystic triangle criterion; CVSII, cystic plate criterion; CVSIII, two structures criterion; CVS, the critical view of safety; DGB, dissecting gallbladder from liver bed; EA, establishing access; EG, extracting the gallbladder; IT, idle time; mAP, mean average precision; MHT, mobilizing the hepatocystic triangle; NA, not applicable.